ArticleFrontiers in immunology2023

Three doses of a recombinant conjugated SARS-CoV-2 vaccine early after allogeneic hematopoietic stem cell transplantation: predicting indicators of a high serologic response-a prospective, single-arm study.

Maryam Barkhordar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.